Oestrogen, cortisol and executive function hormonal cycle

Oestrogen, Cortisol and Executive Function

Geoff Greenwood FCCA MBA MSc · 18 June 2026 · 8 min read

← Back to Insights

She noticed it first on a Tuesday in October. The board presentation was the same one she had delivered three times before — same slides, same data, same room. But something was different. The words came slowly. The connections between ideas that usually formed automatically felt like they needed to be manually assembled. She got through it, professionally, without anyone noticing. But she noticed. She knew what her best thinking felt like, and this was not it.

She attributed it to stress. To the restructuring. To the fact that she had been travelling for three weeks. All of those things were true. But none of them was the primary cause.

What she did not know — what almost no one in her position knows — is that the prefrontal cortex, the region of the brain responsible for the kind of complex, integrative thinking that board presentations require, is exquisitely sensitive to fluctuations in oestrogen. And that Tuesday in October fell on day twenty-two of her cycle, during the luteal phase, when oestrogen levels drop sharply and cortisol reactivity increases. She was not underperforming. She was operating in a biological context that made that specific type of cognitive work significantly harder, and she had no framework for understanding it.

This is not a niche issue. It is a structural one. And the absence of this knowledge from mainstream leadership development is not a minor gap — it is a consequential one.

The Prefrontal Cortex and the Oestrogen Connection

The prefrontal cortex (PFC) is the seat of executive function: working memory, cognitive flexibility, inhibitory control, and the kind of abstract reasoning that senior leadership demands constantly. What most leadership programmes do not mention is that the PFC is densely populated with oestrogen receptors. Research by Agneta Herlitz at the Karolinska Institute and by Bruce McEwen at Rockefeller University has consistently demonstrated that oestrogen modulates dopamine and serotonin transmission in the PFC — the two neurotransmitter systems most directly implicated in working memory and sustained attention.

When oestrogen is high, as it is in the follicular phase (roughly days one to fourteen of the cycle), dopaminergic activity in the PFC is enhanced. Working memory capacity increases. The ability to hold multiple competing ideas in mind simultaneously — the cognitive substrate of strategic thinking — is measurably better. This is not a subjective impression. It is a neurological reality that has been replicated across multiple laboratory and naturalistic settings.

When oestrogen falls, as it does in the mid-to-late luteal phase (roughly days twenty to twenty-eight), that dopaminergic support withdraws. The same cognitive tasks require more effort. Processing speed slows slightly. The sense of cognitive fluency — the feeling that thinking is easy — diminishes. And because the change is gradual rather than sudden, it is almost impossible to attribute to its actual cause without prior knowledge of the mechanism.

Cortisol: The Amplifier

The oestrogen story alone would be significant. But it does not operate in isolation. The relationship between oestrogen and cortisol — the primary stress hormone — is where the performance implications become acute.

Oestrogen has a moderating effect on the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs cortisol release. When oestrogen is high, the HPA axis is relatively buffered: cortisol responses to stressors are more contained and recover more quickly. When oestrogen is low, that buffering diminishes. The same stressor — a difficult conversation, a tight deadline, an unexpected challenge in a meeting — produces a larger cortisol response and a slower return to baseline.

Research by Jill Goldstein at Harvard Medical School has documented this interaction in detail, demonstrating that women in the luteal phase show significantly elevated cortisol reactivity compared to the follicular phase, even when the objective stressor is identical. The practical implication is direct: the same organisational environment that feels manageable in week two of the cycle feels genuinely more demanding in week three — not because the environment has changed, but because the neurological response to it has.

This is not a reason to avoid difficult work in the luteal phase. It is a reason to understand that the difficulty is partly biological, to stop attributing it entirely to inadequacy or circumstance, and to structure the work accordingly.

What the Research Actually Shows About Performance

There is a version of this conversation that slides quickly into the territory of limitation — the implication that women's performance is compromised by their biology in ways that men's is not. That framing is both scientifically inaccurate and strategically unhelpful.

The research shows fluctuation, not deficit. In the follicular phase, particularly in the days around ovulation when oestrogen peaks, cognitive performance on tasks requiring verbal fluency, associative thinking, and complex problem-solving is measurably superior to average. Work by Elizabeth Hampson at the University of Western Ontario demonstrated that women in the high-oestrogen phase of the cycle outperform their own baseline on a range of cognitive tasks — not just match it.

The question is not whether women's cognitive performance is affected by hormonal variation. It is. The question is whether understanding that variation constitutes a performance advantage or disadvantage. The answer is unambiguous: understanding it is an advantage. Not understanding it — and therefore misattributing the variation to personal failings, stress, or circumstance — is the disadvantage.

The Cortisol-Oestrogen Interaction Under Organisational Pressure

Senior leadership roles are not designed around the hormonal cycle. They are designed around the calendar — quarterly reporting cycles, board schedules, project deadlines — and those structures are indifferent to biology. A director who happens to be presenting to the investment committee on day twenty-three of her cycle is not going to reschedule. Nor should she.

But she can prepare differently. She can front-load the cognitive work — the drafting, the complex analysis, the strategic framing — into the days when her PFC is operating with full dopaminergic support. She can schedule the presentation itself with the knowledge that her delivery will be competent and professional even if it does not feel as effortless as it does in week two. She can build in more recovery time after high-stakes events in the luteal phase, knowing that cortisol clearance is slower.

None of this requires disclosing anything to anyone. It requires only that the individual has the framework to understand what is happening and the agency to structure her work around it.

This is what performance optimisation actually looks like in practice. Not generic time management advice. Not mindfulness. A specific understanding of the biological system and a deliberate response to it.

Perimenopause: When the Cycle Stops Being Predictable

For women in their mid-to-late forties — a cohort that includes a significant proportion of senior leaders — the hormonal picture becomes more complex. Perimenopause is not a single event. It is a transition that can last seven to ten years, during which oestrogen levels become erratic rather than cyclical. The predictable fluctuation of the reproductive years is replaced by unpredictable variability: oestrogen surges and crashes without the regularity that allowed for planning.

The cognitive consequences are well-documented. Research by Pauline Maki at the University of Illinois at Chicago has shown that verbal memory, processing speed, and sustained attention are all affected during the perimenopausal transition, with the most significant impairment occurring during periods of rapid oestrogen decline. The cortisol reactivity that characterises the luteal phase becomes a more persistent feature of daily life, rather than a cyclical one.

What is less well-documented — and what matters enormously for senior women — is that these effects are temporary. The cognitive changes associated with perimenopause are not permanent. Post-menopausally, oestrogen stabilises at a lower level, and cognitive function stabilises with it. The transition is the difficult part. Understanding that the difficulty is transitional, not permanent, changes the psychological relationship to it entirely.

Sleep, Recovery, and the Compounding Effect

The oestrogen-cortisol interaction does not operate in isolation from sleep. Oestrogen plays a role in regulating sleep architecture, particularly the proportion of time spent in slow-wave sleep — the phase most associated with memory consolidation and cognitive recovery. When oestrogen falls in the luteal phase, sleep quality often deteriorates: more time in lighter sleep stages, more frequent waking, reduced slow-wave sleep.

The consequence is a compounding effect. Reduced oestrogen impairs PFC function directly. Reduced sleep quality impairs PFC function independently. And elevated cortisol reactivity makes the cognitive demands of the working day feel more effortful. These three mechanisms operate simultaneously, which is why the experience of the luteal phase can feel disproportionately difficult relative to any single cause.

Matthew Walker's research at the University of California, Berkeley, on sleep and cognitive performance has established that even modest sleep disruption — the kind that does not register as a clinical problem — produces measurable impairment in working memory, decision-making, and emotional regulation. When that disruption is hormonally driven and therefore cyclical, the performance implications are systematic rather than occasional.

The Measurement Problem

Here is the practical difficulty: most senior women do not have a baseline. They do not know what their cognitive performance looks like across the cycle because they have never measured it. They have a general sense of good days and bad days, but no framework for understanding the pattern.

This is where objective assessment becomes genuinely useful — not as a diagnostic of deficit, but as a mapping exercise. Understanding your own baseline, and understanding how that baseline varies across the hormonal cycle, is the foundation of deliberate performance optimisation. Without it, you are managing a system you do not understand, attributing variation to causes that are plausible but secondary, and missing the primary lever.

The Exceptional Performance for Women in Leadership programme starts with this mapping. Not because the hormonal cycle is the only variable that matters, but because it is the most systematically ignored one. And ignoring a primary variable in a performance system is not a minor oversight. It is the kind of oversight that compounds quietly over years.

If you have ever had the experience of knowing that your thinking is not at its best, and not being able to explain why, the free assessment is the place to start. It takes fifteen minutes and it will give you more useful information about your performance than most leadership development programmes deliver in a year.

Take the Free Assessment →

Ready to perform at the level your capability demands?

Discover your top performance constraints in 15 minutes — no cost, no commitment.

Take the Free Performance Assessment →